Zhang et al. evaluated the effect of decitabine, a DNA methyltransferase inhibitor, on TGF-β1-induced EMT in NSCLC cells, considering the involvement of the miR-200/ZEB axis. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.